Effects of Nicotinamide Riboside on Metabolism and Vascular Function
NCT03501433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2020-09-25
Summary
The purpose of this study is to determine the effects of Nicotinamide Riboside (NR) supplementation on metabolism and vascular function following high-fat meal. Differences between young (18-35) and older (60-75) adults will be determined.
Conditions
- Aging
- Lipemia
Interventions
- DIETARY_SUPPLEMENT
-
Nicotinamide riboside chloride (Niagen)
250 mg capsules 2x/day for 7 days
- DIETARY_SUPPLEMENT
-
Placebo
2x/day for 7 days
Sponsors & Collaborators
-
Iowa State University
lead OTHER
Principal Investigators
-
Rudy Valentine, PhD · Iowa State University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-02-01
- Primary Completion
- 2019-12-01
- Completion
- 2019-12-01
Countries
- United States
Study Locations
More Related Trials
-
Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects
NCT05905068 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity
NCT02954588 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome
NCT00659321 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants
NCT05091073 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition
NCT02942888 ·Status: COMPLETED ·Phase: NA
-
A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men
NCT05003440 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia
NCT04485793 ·Status: COMPLETED ·Phase: NA
-
Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication
NCT00062556 ·Status: COMPLETED ·Phase: PHASE3
-
Nicotinamide Riboside and Mitochondrial Metabolism
NCT03951285 ·Status: COMPLETED ·Phase: NA
-
The Safety of a Hypolipidemic Agent in Healthy Normal Volunteers
NCT01930240 ·Status: COMPLETED ·Phase: PHASE1
-
the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C
NCT06132360 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)
NCT00519714 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312
NCT02676830 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels
NCT02187757 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia
NCT00244231 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)
NCT00769132 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease
NCT04992065 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease
NCT01391377 ·Status: TERMINATED ·Phase: NA
-
A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood
NCT05979428 ·Status: COMPLETED ·Phase: PHASE1
-
The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC
NCT00071266 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)
NCT01436253 ·Status: COMPLETED
-
Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
NCT02670434 ·Status: WITHDRAWN ·Phase: PHASE3
-
Antioxidant Functions of Lipoic Acid
NCT00065624 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093)
NCT01104519 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia
NCT01645046 ·Status: COMPLETED ·Phase: PHASE2